SAVANNAH COE: Open Payments
NPI 1689348203 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 13 payments from 7 companies in 2025. Trend: 2023 $347 · 2024 $269 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| Novo Nordisk Inc | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| REVANCE THERAPEUTICS, INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, Rybelsus, REXULTI, DAXXIFY, Wegovy, CAPLYTA, UBRELVY, VYEPTI.
Industry payments across TN — which companies pay providers there.
